These are the significant dates in Allergon’s development into a world-leader in allergen source material production.

2007
Cinven acquires Phadia and Allergon as part of their investment portfolio.

2006
Pharmacia Diagnostics, the parent company of Allergon, changes its worldwide name to Phadia.

2004
Allergon sets new standards for mould allergen production, which now takes place in a unique new laboratory facility.

Triton and PPM Ventures acquire Allergon as part of their investment portfolio of companies with strong future potential.

2003
ISO 9001:2000 certification.

2002
Mite allergen production and development unit expanded and improved.

2000
A new modern food allergen unit established.

1995
ISO 9001:1994 certification.

Our own production, development and sales organisation in China, Nanjing Mei Rui Pharma Co., Ltd., established in a joint venture.

1983
Separate facility for epithelia allergen production and development created in line with our strategy of always having separate laboratories for different allergens. Allergens from insects and venoms also added to the portfolio and range.

1981
Allergon Division in Missouri, USA, set up to give access to the American flora in line with our strategy of offering a continuously expanding high-quality range of pollen allergens.

1980
Separate mite allergen production laboratory created. Demand is high and the unit is extended in 1982 and 1988.

1977
Separate mould allergen production facility started, to ensure quality.

1971
Pharmacia acquires Allergon, generating additional resources and accelerating our rapid expansion.

1963
Allergon founded.